Charles Schwab’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Buy |
287,677
+37,450
| +15% | +$2.62M | ﹤0.01% | 1674 |
|
|
2025
Q1 | $18.4M | Sell |
250,227
-1,493,854
| -86% | -$110M | ﹤0.01% | 1681 |
|
|
2024
Q4 | $114M | Sell |
1,744,081
-40,154
| -2% | -$2.63M | 0.02% | 588 |
|
|
2024
Q3 | $139M | Buy |
1,784,235
+8,830
| +0.5% | +$688K | 0.03% | 497 |
|
|
2024
Q2 | $138M | Buy |
1,775,405
+1,666,500
| +1,530% | +$130M | 0.03% | 498 |
|
|
2024
Q1 | $7.38M | Sell |
108,905
-38,346
| -26% | -$2.6M | ﹤0.01% | 2141 |
|
|
2023
Q4 | $9.92M | Buy |
147,251
+24,233
| +20% | +$1.63M | ﹤0.01% | 1991 |
|
|
2023
Q3 | $8.33M | Buy |
123,018
+86,610
| +238% | +$5.87M | ﹤0.01% | 2003 |
|
|
2023
Q2 | $2.61M | Buy |
36,408
+16,736
| +85% | +$1.2M | ﹤0.01% | 2472 |
|
|
2023
Q1 | $1.37M | Buy |
19,672
+7,217
| +58% | +$501K | ﹤0.01% | 2630 |
|
|
2022
Q4 | $844K | Buy |
+12,455
| New | +$844K | ﹤0.01% | 2828 |
|
|
2021
Q1 | – | Sell |
-36,100
| Closed | -$1.81M | – | 3490 |
|
|
2020
Q4 | $1.81M | Sell |
36,100
-208,900
| -85% | -$10.4M | ﹤0.01% | 2615 |
|
|
2020
Q3 | $13.4M | Sell |
245,000
-74,000
| -23% | -$4.06M | 0.01% | 1483 |
|
|
2020
Q2 | $16.9M | Sell |
319,000
-173,700
| -35% | -$9.19M | 0.01% | 1298 |
|
|
2020
Q1 | $22M | Sell |
492,700
-163,800
| -25% | -$7.32M | 0.01% | 950 |
|
|
2019
Q4 | $32.7M | Sell |
656,500
-183,500
| -22% | -$9.15M | 0.02% | 892 |
|
|
2019
Q3 | $37.4M | Hold |
840,000
| – | – | 0.02% | 739 |
|
|
2019
Q2 | $34.7M | Hold |
840,000
| – | – | 0.02% | 775 |
|
|
2019
Q1 | $34M | Buy |
+840,000
| New | +$34M | 0.02% | 773 |
|